SEC Form 5 · accession 0001209191-18-008955
ALDER BIOPHARMACEUTICALS INC · ALDR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Randall C Schatzman
Officer — President and CEO · Director
Period of report
Dec 31, 2017
Accepted (ET)
Feb 9, 2018 · 5:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001423824
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 116,347 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 847 shares that were acquired under the Issuer's 2014 Employee Stock Purchase Plan on May 31, 2017 and 328 shares that were acquired under the Issuer's 2014 Employee Stock Purchase Plan on November 30, 2017. The acquisition of such shares were exempt under Rule 16b-3(c).